These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Utility of serum S100B protein for identification of central nervous system involvement in systemic lupus erythematosus. Fragoso-Loyo H, Cabiedes J, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J. J Rheumatol; 2010 Nov; 37(11):2280-5. PubMed ID: 20716661 [Abstract] [Full Text] [Related]
24. Increase of peripheral T regulatory cells during remission induction with cyclophosphamide in active systemic lupus erythematosus. Tselios K, Sarantopoulos A, Gkougkourelas I, Papagianni A, Boura P. Int J Rheum Dis; 2014 Sep; 17(7):790-5. PubMed ID: 25430593 [Abstract] [Full Text] [Related]
25. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Landolt-Marticorena C, Bonventi G, Lubovich A, Ferguson C, Unnithan T, Su J, Gladman DD, Urowitz M, Fortin PR, Wither J. Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188 [Abstract] [Full Text] [Related]
26. Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus. Yokoyama T, Fujii T, Kondo-Ishikawa S, Yamakawa N, Nakano M, Yukawa N, Yoshifuji H, Ohmura K, Mimori T. Lupus; 2014 Jun; 23(7):635-42. PubMed ID: 24493282 [Abstract] [Full Text] [Related]
27. The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus. Mostafa GA, Ibrahim DH, Shehab AA, Mohammed AK. J Neuroimmunol; 2010 Oct 08; 227(1-2):195-201. PubMed ID: 20724007 [Abstract] [Full Text] [Related]
28. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus. Fragoso-Loyo HE, Sánchez-Guerrero J. J Rheumatol; 2007 Jan 08; 34(1):76-80. PubMed ID: 17143970 [Abstract] [Full Text] [Related]
29. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus. Horai Y, Watanabe H, Miyamura T, Takahama S, Hirata A, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E. Fukuoka Igaku Zasshi; 2010 Feb 08; 101(2):34-40. PubMed ID: 20560477 [Abstract] [Full Text] [Related]
30. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus. Zhang X, Shu H, Zhang F, Tian X, Dong Y. Ann Rheum Dis; 2007 Apr 08; 66(4):530-2. PubMed ID: 16905576 [Abstract] [Full Text] [Related]
31. Antibodies in patients with neuropsychiatric systemic lupus erythematosus. Kimura A, Kanoh Y, Sakurai T, Koumura A, Yamada M, Hayashi Y, Tanaka Y, Hozumi I, Takemura M, Seishima M, Inuzuka T. Neurology; 2010 Apr 27; 74(17):1372-9. PubMed ID: 20421581 [Abstract] [Full Text] [Related]
32. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. Fang H, Lan L, Qu Y, Zhang Q, Lv J. J Int Med Res; 2018 Jan 27; 46(1):485-491. PubMed ID: 28823196 [Abstract] [Full Text] [Related]
33. [Characteristic manifestations of neuropsychiatric systemic lupus erythematosus]. Liu Z, Chen L, Cui LY. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug 27; 27(4):509-12. PubMed ID: 16178450 [Abstract] [Full Text] [Related]
35. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. Bosma GP, Rood MJ, Huizinga TW, de Jong BA, Bollen EL, van Buchem MA. Arthritis Rheum; 2000 Nov 27; 43(11):2428-36. PubMed ID: 11083265 [Abstract] [Full Text] [Related]
36. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus. Tamashiro LF, Oliveira RD, Oliveira R, Frota ER, Donadi EA, Del-Ben CM, Teixeira AL, Louzada-Junior P. Rheumatology (Oxford); 2014 Dec 27; 53(12):2182-90. PubMed ID: 24942492 [Abstract] [Full Text] [Related]
37. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. George-Chandy A, Trysberg E, Eriksson K. Arthritis Res Ther; 2008 Dec 27; 10(4):R97. PubMed ID: 18718031 [Abstract] [Full Text] [Related]
38. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus. Hu C, Huang W, Chen H, Song G, Li P, Shan Q, Zhang X, Zhang F, Zhu H, Wu L, Li Y. PLoS One; 2015 Dec 27; 10(5):e0126643. PubMed ID: 25954975 [Abstract] [Full Text] [Related]
39. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. Santer DM, Yoshio T, Minota S, Möller T, Elkon KB. J Immunol; 2009 Jan 15; 182(2):1192-201. PubMed ID: 19124763 [Abstract] [Full Text] [Related]
40. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Ho RC, Thiaghu C, Ong H, Lu Y, Ho CS, Tam WW, Zhang MW. Autoimmun Rev; 2016 Feb 15; 15(2):124-38. PubMed ID: 26497108 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]